Compare Pyridam Farma Tbk (PYFA) vs Reksa Dana Indeks Mandiri ETF Sri-Kehati (XMSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pyridam Farma Tbk vs Reksa Dana Indeks Mandiri ETF Sri-Kehati — how do they compare? Pyridam Farma Tbk trades at Rp252 (market cap 2.85T, 14.4M 24h volume), while Reksa Dana Indeks Mandiri ETF Sri-Kehati trades at Rp359 (market cap 52.59B). The key difference: Pyridam Farma Tbk is far larger — about 54.2× Reksa Dana Indeks Mandiri ETF Sri-Kehati's market cap. Which is the better fit depends on your goals.
| PYFA | XMSK | |
|---|---|---|
Market Cap | 2.85T | 52.59B |
Volume | 14.4M | — |
Lot | 144.05K | — |
Turnover | 3.62B | — |
Average Price | 251.34 | — |
Value | 3.62B | — |
Indicative Equilibrium Price | 252 | — |
Indicative Equilibrium Volume | 363 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pyridam Farma Tbk
PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.
Read more on PYFA →
